Кращі подкасти про Biotech Startups (2024)

1
🧬 Terry Lo - Vizgen - Part 3 | Transitioning to Vizgen From Akoya | What is Spatial Genomics | The Importance of Genetic Mapping | How to Grow Your Company During Turbulent Times 30:05

2d ago30:05

30:05

As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards. Part 3 of 3. My guest for this week’s episode is Terry Lo, President and CEO of Vizgen. Vizgen is developing and commercializing the next generatio…

1
🧬 Terry Lo - Vizgen - Part 2 | Terry’s Move from Big Pharma to Diagnostics | Introduction to Spatial Biology | Navigating Regulatory & Reimbursement Challenges in Diagnostics | Balancing Multiple Roles ... 30:18

9d ago30:18

30:18

Part 2 of 3. As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards. My guest for this week’s episode is Terry Lo, President and CEO of Vizgen. Vizgen is developing and commercializing the next generatio…

1
🧬 Terry Lo - Vizgen - Part 1 | Leveraging Passion for Science to Succeed in Finance | Sales Excellence as an Introvert Through Competition | Financial Modeling & Creating Proper Deal Structure | How Not ... 38:15

16d ago38:15

38:15

Part 1 of 3. As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” at https://www.excedr.com/rewards. My guest for this week’s episode is Terry Lo, President and CEO of Vizgen. Vizgen is developing and commercializing the next generatio…

1
🧬 Mike Stadnisky - Thielsen Capital - Part 3 | Don’t Fake it ‘Til you Make It | Cleaning Your Corporate “Underwear” | Thielsen’s Investment Philosophy | The Critical Importance of Alignment 57:58

23d ago57:58

57:58

Part 3 of 3. My guest for this week’s episode is Mike Stadnisky, Managing Director of Thielsen Capital. Thielsen Capital is a seed-stage financing syndicate network bringing together life science investors, operators, and innovators to drive exceptional outcomes for founding teams, investors, and science. Before Thielsen, Mike was the CEO of Phiton…

1
🧬 Mike Stadnisky - Thielsen Capital - Part 2 | Transitioning from Academia to Business | Breaking Into Business Development | Finding Decision Makers & Champions | Navigating Partnerships & Strategy 34:46

1M ago34:46

34:46

Part 2 of 3. My guest for this week’s episode is Mike Stadnisky, Managing Director of Thielsen Capital. Thielsen Capital is a seed-stage financing syndicate network bringing together life science investors, operators, and innovators to drive exceptional outcomes for founding teams, investors, and science. Before Thielsen, Mike was the CEO of Phiton…

1
🧬 Mike Stadnisky - Thielsen Capital - Part 1 | Familial Exposure to Business & Science at a Young Age | The Importance of “Care Before You Share” | Actively Managing Your Time | A PhD is a 10,000 Hour ... 50:51

1M ago50:51

50:51

Part 1 of 3. My guest for this week’s episode is Mike Stadnisky, Managing Director of Thielsen Capital. Thielsen Capital is a seed-stage financing syndicate network bringing together life science investors, operators, and innovators to drive exceptional outcomes for founding teams, investors, and science. Before Thielsen, Mike was the CEO of Phiton…

1
🧬 Martin Brenner - iBio - Part 3 | Transitioning from Big Pharma to Biotech Startups | Lessons in Flexibility, Resilience, & Adaptability | Challenging Long-Held Beliefs in Drug Discovery | The Evolution ... 1:21:04

1M ago1:21:04

1:21:04

Part 3 of 3. My guest for this week’s episode is Martin Brenner, CEO and CSO of iBio. iBio uses its AI drug discovery platform to tackle complex and challenging drug targets to develop safer and more effective immunotherapies for difficult-to-treat cancers. Rather than leaving drug discovery to chance, iBio guides the process using artificial intel…

1
🧬 Martin Brenner - iBio - Part 2 | Autonomy at Eli Lilly vs. Structure at Pfizer | Transitioning from AstraZeneca to Merck | Joys & Challenges When Relocating for Work | A Biotech Vision Leading to an ... 36:53

2M ago36:53

36:53

As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards. Part 2 of 3. My guest for this week’s episode is Martin Brenner, CEO and CSO of iBio. iBio uses its AI drug discovery platform to tackle complex an…

1
🧬 Martin Brenner - iBio - Part 1 | How Childhood Influences Shape Career Paths | Unexpected Crossovers Between Engineering & Veterinary Clinics | Eli Lilly Nurturing His Professional Development | Communication ... 33:31

2M ago33:31

33:31

As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards. Part 1 of 3. My guest for this week’s episode is Martin Brenner, CEO and CSO of iBio. iBio uses its AI drug discovery platform to tackle complex an…

1
🧬 Jeff Kim - Slingshot Biosciences - Part 3 | Bucking the Status Quo | Raising Capital During Peak COVID | How To Find & Retain Great Talent | Building Partnerships with Distributors 28:52

2M ago28:52

28:52

As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards. Part 3 of 3. My guest for this week’s episode is Jeff Kim, co-founder and CEO of Slingshot Biosciences. Slingshot designs and manufactures syntheti…

1
🧬 Jeff Kim - Slingshot Biosciences - Part 2 | Working Toward One Goal In Industry | How Great Loss Prompted Professional Growth | Transitioning From a Basement Lab to a Thriving Company | A 6-Month Startup ... 31:23

2M ago31:23

31:23

As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards. Part 2 of 3. My guest for this week’s episode is Jeff Kim, co-founder and CEO of Slingshot Biosciences. Slingshot designs and manufactures syntheti…

1
🧬 Jeff Kim - Slingshot Biosciences - Part 1 | Parental Freedom, Curiosity, & Self-Teaching | Music Accentuating a Passion for Science | The Benefits of Graduate Responsibilities as an Undergrad | Finding ... 28:32

3M ago28:32

28:32

As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards. Part 1 of 3. My guest for this week’s episode is Jeff Kim, co-founder and CEO of Slingshot Biosciences. Slingshot designs and manufactures syntheti…

1
🧬 Stephanie Sirota - RTW Investments - Part 3 | The Emergence of Crossover Rounds | Building & Explaining Your Investment Thesis | Creating a .600 Batting Average Investment Fund | Transparency Between ... 31:10

3M ago31:10

31:10

Part 3 of 3. My guest for this week’s episode is Stephanie Sirota, Partner, and Chief Business Officer at RTW Investments, a full lifecycle life sciences investment firm dedicated to solving the most challenging unmet patient needs. Stephanie is a seasoned expert and leader in business development, strategic partnerships, communications, and invest…

1
🧬 Stephanie Sirota - RTW Investments - Part 2 | Understanding Investment Banking’s Role in the Biosciences | Finding the Benefits of Your Uniqueness | Unexpected Pivots & Finding Passion in Your Work ... 32:42

3M ago32:42

32:42

Part 2 of 3. My guest for this week’s episode is Stephanie Sirota, Partner, and Chief Business Officer at RTW Investments, a full lifecycle life sciences investment firm dedicated to solving the most challenging unmet patient needs. Stephanie is a seasoned expert and leader in business development, strategic partnerships, communications, and invest…

1
🧬 Stephanie Sirota - RTW Investments - Part 1 | Early Influences on Leadership Style | Competitive Tennis Fosters Professional Drive | The Inverse Importance of Coaching | The Ending of a Dream to Open ... 24:03

3M ago24:03

24:03

Part 1 of 3. My guest for this week’s episode is Stephanie Sirota, Partner, and Chief Business Officer at RTW Investments, a full lifecycle life sciences investment firm dedicated to solving the most challenging unmet patient needs. Stephanie is a seasoned expert and leader in business development, strategic partnerships, communications, and invest…

1
🧬 Kittu Kolluri - Neotribe Ventures - Part 3 | Influence vs Control as a VC | Being a Leader in Venture vs a Leader in a Company | Starting Neotribe as a Passionate Rage Against the Status Quo | Sunk Cost ... 36:51

4M ago36:51

36:51

Part 3 of 3. My guest for this week’s episode is Kittu Kolluri, Founder and Managing Director of Neotribe Ventures, an early- and growth-stage venture capital firm investing in companies that solve hard technical problems and disrupt non-traditional industry sectors. Neotribe is led by a team of serial entrepreneurs with a track record of supportin…

1
🧬 Kittu Kolluri - Neotribe Ventures - Part 2 | The Importance of Co-Authoring a Culture Statement | The Difference Between Leadership & Management | Raising Funds in Down-Market Conditions | The Value ... 31:59

4M ago31:59

31:59

Part 2 of 3. My guest for this week’s episode is Kittu Kolluri, Founder and Managing Director of Neotribe Ventures, an early- and growth-stage venture capital firm investing in companies that solve hard technical problems and disrupt non-traditional industry sectors. Neotribe is led by a team of serial entrepreneurs with a track record of supportin…

1
🧬 Kittu Kolluri - Neotribe Ventures - Part 1 | Entrepreneurship as a First-Generation Immigrant | Working & Growing at Silicon Graphics | Learning From Mistakes & Pride of Ownership | The Dangers of Company ... 35:11

4M ago35:11

35:11

Part 1 of 3. My guest for this week’s episode is Kittu Kolluri, Founder and Managing Director of Neotribe Ventures, an early- and growth-stage venture capital firm investing in companies that solve hard technical problems and disrupt non-traditional industry sectors. Neotribe is led by a team of serial entrepreneurs with a track record of supportin…

1
🧬 Fengru Lin - TurtleTree - Part 3 | The Value of Early HR for Company Building | Creating a People-First Work Culture | Refocusing to Reach Commercialization Sooner | Navigating Seed Series Fundraising ... 29:25

4M ago29:25

29:25

Part 3 of 3. My guest for this week’s episode is Fengru Lin, Founder and CEO of TurtleTree, a biotech company revolutionizing food for good. Having raised a 40 million dollar Series A, TurtleTree is creating cell-based milk, with a current focus on releasing LF+, the world’s first sustainably produced lactoferrin made with cutting-edge precision fe…

1
🧬 Fengru Lin - TurtleTree - Part 2 | Salesforce’s Customer-Centric Sales Motion | The Value of Knowing Your Audience in Every Conversation | Why Executive Buy-In Matters | How a Hobby Led to TurtleTree ... 24:23

5M ago24:23

24:23

Part 2 of 3. My guest for this week’s episode is Fengru Lin, Founder and CEO of TurtleTree, a biotech company revolutionizing food for good. Having raised a 40 million dollar Series A, TurtleTree is creating cell-based milk, with a current focus on releasing LF+, the world’s first sustainably produced lactoferrin made with cutting-edge precision fe…

1
🧬 Fengru Lin - TurtleTree - Part 1 | Growing Up in Hong Kong & Singapore | Serendipity & Its Effect on Career Paths | Connecting the Dots in Business | The Complex & Fragile World of Food Production ... 22:45

5M ago22:45

22:45

Part 1 of 3. My guest for this week’s episode is Fengru Lin, Founder and CEO of TurtleTree, a biotech company revolutionizing food for good. Having raised a 40 million dollar Series A, TurtleTree is creating cell-based milk, with a current focus on releasing LF+, the world’s first sustainably produced lactoferrin made with cutting-edge precision fe…

1
🧬 Sandy Paige - Seabright Ventures Fund - Part 4 | Creating Competitive Moats | Leveraging Financing Opportunities for Growth | The Purpose of a Board of Directors | Ambiguity as an Asset & Avoiding the ... 29:11

5M ago29:11

29:11

Part 4 of 4. My guest for this week’s episode is Sandy Paige, co-managing director of the Seabright Ventures Fund, a search fund investing in the US middle market, with a focus on life sciences and cleantech. Sandy is an expert CEO, most recently leading and scaling Explora BioLabs before its acquisition by Charles River Laboratories for $295 Milli…

1
🧬 Sandy Paige - Seabright Ventures Fund - Part 3 | Managing International Distribution | Meaningful Work & Personal Buy-In as a Form of Equity | Getting Into Business Development & The Importance of Sales ... 23:46

5M ago23:46

23:46

Part 3 of 4. My guest for this week’s episode is Sandy Paige, co-managing director of the Seabright Ventures Fund, a search fund investing in the US middle market, with a focus on life sciences and cleantech. Sandy is an expert CEO, most recently leading and scaling Explora BioLabs before its acquisition by Charles River Laboratories for $295 Milli…

1
🧬 Sandy Paige - Seabright Ventures Fund - Part 2 | Practicing Corporate Entrepreneurship | Life Lessons on How to Treat People | Seeking Margins & Avoiding Commodity | Scaling a Non-Profit | A CEO’s 3 ... 36:05

6M ago36:05

36:05

Part 2 of 4. My guest for this week’s episode is Sandy Paige, co-managing director of the Seabright Ventures Fund, a search fund investing in the US middle market, with a focus on life sciences and cleantech. Sandy is an expert CEO, most recently leading and scaling Explora BioLabs before its acquisition by Charles River Laboratories for $295 Milli…

1
🧬 Sandy Paige - Seabright Ventures Fund - Part 1 | The Value of Hustle & Being a Team Player | Saying Yes to Opportunities | Corporate Entrepreneurship & Finding Your Path | Entrepreneurs & Risk Aversion ... 30:30

6M ago30:30

30:30

Part 1 of 4. My guest for this week’s episode is Sandy Paige, co-managing director of the Seabright Ventures Fund, a search fund investing in the US middle market, with a focus on life sciences and cleantech. Sandy is an expert CEO, most recently leading and scaling Explora BioLabs before its acquisition by Charles River Laboratories for $295 Milli…

1
🧬 Maneesh Jain - Mirvie - Part 3 | Finding & Addressing Unmet Needs | The Maternal Health Crisis | Creating an Empathy-Focused Company Culture | Fundraising & Hitting Milestones in a Recession 26:00

6M ago26:00

26:00

Part 3 of 3. My guest for this week’s episode is Maneesh Jain, CEO and Co-Founder of Mirvie, a life science company that predicts pregnancy complications before they happen by revealing the underlying biology of pregnancy health. Mirvie is dedicated to shaping the future of pregnancy health through simple, personalized blood tests. Before Mirvie, M…

1
🧬 Maneesh Jain - Mirvie - Part 2 | Company Size & Innovation | Supply Chain Learnings from Other Industries | Scaling Go-to-Market Strategies | Culture’s Interaction with Mergers & Acquisitions 29:02

6M ago29:02

29:02

Part 2 of 3. My guest for this week’s episode is Maneesh Jain, CEO and Co-Founder of Mirvie, a life science company that predicts pregnancy complications before they happen by revealing the underlying biology of pregnancy health. Mirvie is dedicated to shaping the future of pregnancy health through simple, personalized blood tests. Before Mirvie, M…

1
🧬 Maneesh Jain - Mirvie - Part 1 | Fundamental Curiosity & The Value of Perseverance | Entrepreneurship for Societal Impact | “Magic Decades” & Finding Your Niche | The Importance of Scalability & Differentiation ... 31:07

7M ago31:07

31:07

Part 1 of 3. My guest for this week’s episode is Maneesh Jain, CEO and Co-Founder of Mirvie, a life science company that predicts pregnancy complications before they happen by revealing the underlying biology of pregnancy health. Mirvie is dedicated to shaping the future of pregnancy health through simple, personalized blood tests. Before Mirvie, M…

1
🧬 Alok Tayi - Vibe Bio - Part 3 | Biotech2050 Podcast Origins | Facilitating Innovation Conversations in Biotech | Vibe Bio’s Mission & Funding Cures Instead of Finding Them | Non-Linear Growth & Thinking ... 26:40

7M ago26:40

26:40

Part 3 of 3. My guest for this week’s episode is Alok Tayi, Founder of Vibe Bio, a life science company that funds and guides high-potential drug programs through value inflection points. Vibe Bio’s core comprises a community of scientists, patients, and partners dedicated to helping biotechs find the promising treatments that patients deserve. Pri…

1
🧬 Alok Tayi - Vibe Bio - Part 2 | Transitioning Into Entrepreneurship | The Importance of Sales Experience for Founders | The Power of a .edu Email | Managing Personnel During Hyperscaling 27:03

8M ago27:03

27:03

Part 2 of 3. My guest for this week’s episode is Alok Tayi, Founder of Vibe Bio, a life science company focused on funding & guiding high-potential drug programs through value inflection points. Vibe Bio’s core comprises a community of scientists, patients, and partners dedicated to helping biotechs find the promising treatments that patients deser…

1
🧬 Alok Tayi - Vibe Bio - Part 1 | Combining Software & Science | The Influence of Serendipity on Trajectory | The Critical Importance of Mentors | Working to Make an Impact & Solve Problems 30:27

8M ago30:27

30:27

Part 1 of 3. My guest for this week’s episode is Alok Tayi, Founder of Vibe Bio, a life science company focused on funding & guiding high-potential drug programs through value inflection points. Vibe Bio’s core is a community of scientists, patients, and partners that are dedicated to helping biotechs find the promising treatments that patients des…

1
🧬 James Evans - PhenoVista - Part 3 | Being a Scrappy Founder | Adapting to Change & Learning to Pivot | The Importance of Professional Business Development | Setting Client Expectations 19:01

8M ago19:01

19:01

Part 3 of 3. My guest for this week’s episode is James Evans, Founder and CEO of PhenoVista Biosciences, a contract research organization that works with biopharma clients of all sizes, from start-ups to established global companies. Before starting PhenoVista, James spent a decade at MIT’s Whitehead Institute for Biomedical Research as a Postdoc, …

1
🧬 James Evans - PhenoVista - Part 2 | Leaving Academia for Industry | How to Handle Miscommunication | Creating a Truly Diverse Company Culture | Being Bootstrapped & Forging a Business Model in the Real ... 22:05

9M ago22:05

22:05

Part 2 of 3. My guest for this week’s episode is James Evans, Founder and CEO of PhenoVista Biosciences, a contract research organization that works with biopharma clients of all sizes, from start-ups to established global companies. Before starting PhenoVista, James spent a decade at MIT’s Whitehead Institute for Biomedical Research as a Postdoc, …

1
🧬 James Evans - PhenoVista - Part 1 | Skateboarding, Resilience, & Problem Solving | The Importance of Hands-On Lab Experiences | The Elegant Simplicity of Trial & Error | Running the Whitehead Institute ... 27:52

9M ago27:52

27:52

Part 1 of 3. My guest for this week’s episode is James Evans, Founder and CEO of PhenoVista Biosciences, a contract research organization that works with biopharma clients of all sizes, from start-ups to established global companies. Before starting PhenoVista, James spent a decade at MIT’s Whitehead Institute for Biomedical Research as a Postdoc, …

1
🧬 Steve Visco - PolyPlus - Part 3 | Government Grants | The Importance of Storytelling for STEM Startups | Venture Capital vs Non-Dilutive Funding | How To Gain Strategic Corporate Interest Domestically ... 37:21

10M ago37:21

37:21

Part 3 of 3. My guest for this week’s episode is Steve Visco. Steve is the Co-founder, CTO, and CEO of PolyPlus. Before PolyPlus, Steve worked at Lawrence Berkeley National Lab as a Principal Investigator, running several programs in the field of solid state ionics, developing an extensive patent portfolio, much of which has been licensed to indust…

1
🧬 Steve Visco - PolyPlus - Part 2 | Global Competition | Defending & Monetizing Your Intellectual Property | Dealing With Patent Trolls & Needing Multiple Patents Per Technology | The Importance of Global ... 34:22

10M ago34:22

34:22

Part 2 of 3. My guest for this week’s episode is Steve Visco. Steve is the Co-founder, CTO, and CEO of PolyPlus. Before PolyPlus, Steve worked at Lawrence Berkeley National Lab as a Principal Investigator, running several programs in the field of solid state ionics, developing an extensive patent portfolio, much of which has been licensed to indust…

1
🧬 Steve Visco - PolyPlus - Part 1 | Benefits of Strong Writing Skills for Entrepreneurs | Tech Transfer Process & Its Origins | Leveraging Your Expert Status in Negotiations to Gain Investment | Evaluating ... 35:37

11M ago35:37

35:37

Part 1 of 3. My guest for this week’s episode is Steve Visco. Steve is the Co-founder, CTO, and CEO of PolyPlus. Before PolyPlus, Steve worked at Lawrence Berkeley National Lab as a Principal Investigator, running several programs in the field of solid state ionics, developing an extensive patent portfolio, much of which has been licensed to indust…

1
🧬 Jacob Glanville - Centivax - Part 4 | How to Choose the Right Venture Capital Partner | Fundraising as “Dating” | Finding Proper Alignment & The Win-Win | VC Network as a “Polishing Engine” 31:27

11M ago31:27

31:27

Part 4 of 4. My guest for this week’s episode is Jacob Glanville. Jacob is the Founder, CEO, and President of Centivax and was formerly the Co-founder, CEO, and President of Distributed Bio. Join us as we sit down with Jake to discuss: how important it is to understand a venture capital firm’s investment thesis and values, tips to successfully pitc…

1
🧬 Jacob Glanville - Centivax - Part 3 | Building a Biotech without Venture Capital | Picking Lab Space & Company Growth | Equipment Leasing & Runway/Cash Flow Maximization | Process Drift & “The Respiration ... 34:35

12M ago34:35

34:35

Part 3 of 4. My guest for this week’s episode is Jacob Glanville. Jacob is the Founder, CEO, & President of Centivax and was formerly the Co-founder, CEO, and President of Distributed Bio. Join us as we sit down with Jake, discussing his three-part plan for building Distributed Bio without traditional venture capital, how reality differed from the …

1
🧬 Jacob Glanville - Centivax - Part 2 | Creating Bioinformatic Tools | Innovation vs. Organization in Biotech Companies | Finding Excitement in Your Work | Tech Transfer & “Separation of Church and State ... 31:25

1y ago31:25

31:25

Part 2 of 4. My guest for this week’s episode is Jacob Glanville. Jacob is the Founder, CEO, & President of Centivax and was formerly the Co-founder, CEO, and President of Distributed Bio. Join us as we sit down with Jake, discussing his time at Rinat Labs, a Pfizer company, and how he found a way to leverage his skills and experience to create new…

1
🧬 Jacob Glanville - Centivax - Part 1 | Hospitality Industry’s Applied Lessons | The Benefits of Contingency Planning & Fair Negotiation | How to Seek Translational Skill Sets & Cross Training 24:38

1y ago24:38

24:38

Part 1 of 4. My guest for this week’s episode is Jacob Glanville. Jacob is the Founder, CEO, & President of Centivax and was formerly the Co-founder, CEO, and President of Distributed Bio. Join us as we sit down with Jake and talk about how our upbringing and experiences shape us, helping us find success in life science careers. Learn more about th…

1
🧬 The Biotech Startups Podcast Trailer 0:59

1+ y ago0:59

0:59

The Biotech Startups Podcast is handcrafted by our friends over at: fame.soExcedr

Подкасти, які варто послухати

Подкасти на тему Biotech Startups

Подкасти, які варто послухати

Короткий довідник